Dana Point, California
United States
225
2025-12-11
The entities that hold a legal rights for patent applications filed by inventor Donello John E.:
John E. Donello from Dana Point, US has applied for patents for these inventions. The list has both pending applications and granted patents:
PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETHYL]-3H-IMIDAZOLE DERIVATIVES FOR TREATING RETINAL DISEASES
#2 | 2025-07-17PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL)METHANOL
#3 | 2024-12-053,4-DISUBSTITUTED 3-CYCLOBUTENE-1,2-DIONES AND USE THEREOF
#4 | 2024-08-29AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDERECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS
#5 | 2023-03-02METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
#6 | 2022-12-223,4-DISUBSTITUTED 3-CYCLOBUTENE-1,2-DIONES AND USE THEREOF
#7 | 2022-07-28PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETHYL]-3H-IMIDAZOLE DERIVATIVES FOR TREATING RETINAL DISEASES
#8 | 2022-06-30AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS
#9 | 2022-01-13PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL)METHANOL
#10 | 2021-01-14USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLOGICAL DISEASES
#11 | 2021-01-07USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLOGICAL DISEASES
#12 | 2020-12-17Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases
#13 | 2020-10-22METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
#14 | 2020-08-06Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
#15 | 2020-07-02PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL)METHANOL
#16 | 2020-06-04PROSTACYCLIN RECEPTOR AGONISTS FOR REDUCTION OF BODY FAT
#17 | 2020-04-09Sulfur derivatives as chemokine receptor modulators
#18 | 2019-11-14Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#19 | 2019-08-08Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases
#20 | 2019-06-27COMPOSITIONS INCLUDING ENCAPSULATED ISOTRETINOIN AND METHODS FOR USE THEREOF
#21 | 2019-05-23Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
#22 | 2019-02-143,4-disubstituted 3-cyclobutene-1,2-diones and use thereof
#23 | 2018-12-06METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
#24 | 2018-08-16Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#25 | 2018-03-15METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
#26 | 2018-03-15Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
#27 | 2017-11-09Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
#28 | 2017-08-03Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
#29 | 2017-06-29Carbamoyl hydrazine derivatives as formyl peptide modulators
#30 | 2017-06-29Pharmaceutical compositions comprising 7-(1H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
#31 | 2017-06-22PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL)METHANOL
#32 | 2017-06-22Methods of treating α adrenergic mediated conditions
#33 | 2017-06-22D-SERINE FOR THE TREATMENT OF VISUAL SYSTEM DISORDERS
#34 | 2017-05-04Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#35 | 2017-04-06PHARMACEUTICAL COMPOSITIONS COMPRISING 7-(1H-IMIDAZOL-4-YLMETHYL)-5,6,7,8-TETRAHYDRO-QUINOLINE FOR TREATING SKIN DISEASES AND CONDITIONS
#36 | 2017-03-23METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RECEPTOR AGONISTS
#37 | 2017-02-23Sulfur derivatives as chemokine receptor modulators
#38 | 2016-12-08ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING SKIN DISEASES AND CONDITIONS
#39 | 2016-10-20PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETHYL]-3HIMIDAZOLE DERIVATIVES FOR TREATING RETINAL DISEASES
#40 | 2016-09-15Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
#41 | 2016-08-18Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#42 | 2016-08-111,2- bis-sulfonamide derivatives as chemokine receptor modulators
#43 | 2016-06-09Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
#44 | 2016-06-02PHARMACEUTICAL COMPOSITIONS COMPRISING 7-(1H-IMIDAZOL-4-YLMETHYL)-5,6,7,8-TETRAHYDRO-QUINOLINE FOR TREATING SKIN DISEASES AND CONDITIONS
#45 | 2016-04-07Treatment of inflammatory bowel disease
#46 | 2016-03-241-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
#47 | 2016-03-24Sulfur derivatives as chemokine receptor modulators
#48 | 2016-03-10PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL)METHANOL
#49 | 2016-02-25Methods for treating cognitive disorders using 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds
#50 | 2016-02-25PHARMACEUTICAL COMPOSITIONS COMPRISING 7-(1H-IMIDAZOL-4-YLMETHYL)-5,6,7,8- TETRAHYDRO-QUINOLINE FOR TREATING SKIN DISEASES AND CONDITIONS
#51 | 2015-10-15Carbamoyl hydrazine derivatives as formyl peptide modulators
#52 | 2015-09-10PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETHYL]-3HIMIDAZOLE DERIVATIVES FOR TREATING RETINAL DISEASES
#53 | 2015-08-20METHODS FOR TREATING COGNITIVE DISORDERS USING 1-BENZYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS
#54 | 2015-08-20Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
#55 | 2015-08-13Methods of treating α adrenergic mediated conditions
#56 | 2015-08-06Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators
#57 | 2015-07-30Alpha adrenergic receptor modulators
#58 | 2015-06-11Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
#59 | 2015-05-28Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#60 | 2015-01-22Derivatives of N-urea substituted amino acids as formyl peptide receptor modulators
#61 | 2015-01-15Treatment of inflammatory bowel disease
#62 | 2014-12-25SULFUR DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS
#63 | 2014-11-06Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulators
#64 | 2014-10-16Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
#65 | 2014-09-18ALPHA-2 ADRENERGIC AGONIST FOR TREATING INTRAOCULAR PRESSURE AND OCULAR DISEASES THROUGH INTRAVITREAL AND INTRACAMERAL ROUTES
#66 | 2014-09-18Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators
#67 | 2014-09-18Compositions including encapsulated isotretinoin and methods for use thereof
#68 | 2014-09-11USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLOGICAL DISEASES
#69 | 2014-09-11Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
#70 | 2014-08-21PHARMACEUTICAL COMPOSITIONS COMPRISING 4-BROMO-N-(IMIDAZOLIDIN-2-YLIDENE)-1H-BENZIMIDAZOL-5-AMINE FOR TREATING SKIN DISEASES
#71 | 2014-08-07Sulfur derivatives as chemokine receptor modulators
#72 | 2014-08-07NOVEL 1,2- BIS-SULFONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS
#73 | 2014-06-26METHODS FOR TREATING COGNITIVE DISORDERS USING 3-ARYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES, 3-HETEROARYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS
#74 | 2014-05-08Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
#75 | 2014-04-17METHODS FOR TREATING COGNITIVE DISORDERS
#76 | 2014-04-17THERAPEUTIC QUINOLINE AND NAPHTHALENE DERIVATIVES
#77 | 2014-04-03Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#78 | 2014-03-06Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
#79 | 2014-02-27Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases
#80 | 2014-02-201,2- bis-sulfonamide derivatives as chemokine receptor modulators
#81 | 2014-01-09S1P3 RECEPTOR INHIBITORS FOR TREATING PAIN
#82 | 2013-12-191-1-Oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
#83 | 2013-12-196-SUBSTITUTED INDOLE-3-CARBOXYLIC ACID AMIDE COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR ANTAGONIST BIOLOGICAL ACTIVITY
#84 | 2013-12-12Aryl urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
#85 | 2013-11-211-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
#86 | 2013-11-07ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING SKIN DISEASES AND CONDITIONS
#87 | 2013-10-31ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR LOWERING INTRAOCULAR PRESSURE
#88 | 2013-10-17(2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators
#89 | 2013-09-26Sulfur derivatives as chemokine receptor modulators
#90 | 2013-09-12Sulfur derivatives as chemokine receptor modulators
#91 | 2013-09-05Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulators
#92 | 2013-09-05Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators
#93 | 2013-08-22Imidazolidine-2,4-dione derivatives as N-formyl peptide receptor 2 modulators
#94 | 2013-08-22METHOD OF REDUCING THE SEVERITY OF INFLAMMATORY DERMATOLOGICAL CONDITIONS
#95 | 2013-08-15ALPHA-2 ADRENERGIC AGONIST HAVING LONG DURATION OF INTRAOCULAR PRESSURE-LOWERING EFFECT
#96 | 2013-08-08Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
#97 | 2013-08-083-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-aminopropionic acid amides and related compounds having analgesic and/or immuno stimulant activity
#98 | 2013-08-01BRIMONIDINE FOR TREATING VISUAL DISORDERS MEDIATED BY CENTRAL VISUAL PROJECTIONS FROM THE EYE
#99 | 2013-07-25Sulfur derivatives as chemokine receptor modulators
#100 | 2013-06-27Sulfur derivatives as chemokine receptor modulators
13903 ⎘